3billion is a biotechnology company focused on advancing genomic medicine and personalized healthcare solutions. The company specializes in providing comprehensive genomic analysis and interpretation services, aiming to enhance the understanding of genetic variations and their implications for health. Through innovative technology and data analytics, 3billion seeks to empower healthcare professionals and patients with actionable insights derived from genomic data, ultimately improving diagnosis and treatment options in various medical fields.